|
|
Volumn 14, Issue 6, 1996, Pages 1753-1755
|
|
One hundred thirteen men with hormone-refractory prostate cancer died today
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIANDROGEN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
ESTRAMUSTINE;
ETOPOSIDE;
FLUOROURACIL;
KETOCONAZOLE;
LIAROZOLE;
MEGESTROL ACETATE;
MITOXANTRONE;
NAVELBINE;
PACLITAXEL;
PAMIDRONIC ACID;
PREDNISONE;
PROSTATE SPECIFIC ANTIGEN;
CANCER HORMONE THERAPY;
CANCER PAIN;
COST BENEFIT ANALYSIS;
DOSE RESPONSE;
DRUG EFFICACY;
EDITORIAL;
HEALTH CARE COST;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
MALE;
NEUTROPENIA;
PRIORITY JOURNAL;
PROSTATE CANCER;
QUALITY OF LIFE;
SURVIVAL RATE;
|
|
EID: 0029994108
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.1996.14.6.1753 Document Type: Editorial |
|
Times cited : (26)
|
|
References (0)
|
